Cancer and Chemotherapy Reviews
SJR0.103
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.103 | Q4 | 0.2% | |
| 2024 | — | — | 0.102 | Q4 | 3.4% | |
| 2023 | — | — | 0.105 | Q4 | 11.5% | |
| 2022 | — | — | 0.119 | Q4 | 20.7% | |
| 2021 | — | — | 0.116 | Q4 | 22.2% | |
| 2020 | — | — | 0.113 | Q4 | 7.0% | |
| 2019 | — | — | 0.104 | Q4 | 9.2% | |
| 2018 | — | — | 0.111 | Q4 | 2.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2339-8728
ISSN
1885-740X
region
Western Europe
coverage
2007-2022, 2024-2025